Status:
COMPLETED
Post-operative Pain Control of Testicular Sperm Extraction Using Liposomal Bupivacaine
Lead Sponsor:
Weill Medical College of Cornell University
Collaborating Sponsors:
Pacira Pharmaceuticals, Inc
Conditions:
Male Infertility
Eligibility:
MALE
18-99 years
Phase:
PHASE4
Brief Summary
The study is a drug trial comparing the post-operative pain control provided by liposomal bupivacaine (a local anesthetic) against standard bupivacaine (a different formulation of the local anesthetic...
Eligibility Criteria
Inclusion
- Men scheduled for surgical sperm retrieval for infertility
- Men 18 years and older who can provide informed consent
- No documented allergy to bupivacaine or celecoxib
Exclusion
- Prior history of substance abuse
- Any narcotic use within the last 3 months
- Concomitant use of aspirin
- Any of the following comorbidities: renal failure, heart disease, peptic ulcer disease, cerebrovascular disease, significant liver disease, untreated depression, chronic pain disorder, or bleeding diatheses
- Medical history or concurrent illness that the investigator considers sufficiently serious to interfere with the conduct, completion, or results of this trial, or constitutes an unacceptable risk to the subject
Key Trial Info
Start Date :
February 4 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 30 2020
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03802864
Start Date
February 4 2019
End Date
January 30 2020
Last Update
December 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Weill Cornell Medicine Department of Urology
New York, New York, United States, 10065